{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:59:39Z","timestamp":1790441979830,"version":"4.1.0"},"reference-count":84,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL102547"],"award-info":[{"award-number":["HL102547"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI163090"],"award-info":[{"award-number":["AI163090"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI184205"],"award-info":[{"award-number":["AI184205"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transplant Infectious Dis"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:label\/>\n                    <jats:p>Cytomegalovirus (CMV) remains one of the most common and consequential pathogens in solid organ transplant (SOT) and allogeneic hematopoietic cell transplant (HCT) despite current prevention strategies. Even a partially effective CMV vaccine could reduce morbidity and mortality associated with CMV in SOT recipients (SOTr) and HCT recipients (HCTr), as well as decrease costs, toxicities, and the risk of antiviral resistance. Despite progress since the first CMV vaccine (Towne) was developed in the 1970s, no CMV vaccine has achieved regulatory approval. Differences in CMV epidemiology, host risk factors, and immune reconstitution between SOTr and HCTr, and heterogeneity in CMV vaccination goals across transplant populations, complicate the development of CMV vaccine candidates in transplantation. Incompletely defined immune correlates of protection and logistical barriers inherent to CMV vaccine clinical trial execution, such as unpredictable timing of transplantation and variable access to central laboratory monitoring, create additional challenges. This review describes the potential benefits of a CMV vaccine in HCTr and SOTr, summarizes prior trials of CMV vaccines in transplantation and the lessons learned, and provides a framework for overcoming historical barriers with innovative trial designs and validated biologic endpoints in the modern era of CMV prophylaxis to advance CMV vaccine candidates through clinical stages of development.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/tid.70329","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:30:32Z","timestamp":1790440232000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytomegalovirus Vaccines in Transplantation: History, Hurdles, and Hope"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3595-2071","authenticated-orcid":false,"given":"Matthew L.","family":"Goodwin","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases Department of Medicine Duke University School of Medicine  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5350-9025","authenticated-orcid":false,"given":"Ajit P.","family":"Limaye","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Department of Medicine University of California San Francisco  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9424-1870","authenticated-orcid":false,"given":"Madeleine R.","family":"Heldman","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases Department of Medicine Duke University School of Medicine  Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,26]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae321"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae535"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004352"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13512"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra064928"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.26045"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2026.03.017"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2024.102039"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu364"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277\u2010019\u201003669\u2010z"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102015\u201011\u2010679639"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706640"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399\u20103062.2010.00504.x"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352\u20103026(23)00344\u20107"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab1064"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2024.03.001"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz389"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2024.05.021"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(00)02607\u20106"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.3138"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023012175"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad169"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.9106"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198207013070102"},{"issue":"5","key":"e_1_2_12_26_1","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1182\/blood.V78.5.1373.1373","article-title":"Cytotoxic T\u2010Lymphocyte Response to Cytomegalovirus After Human Allogeneic Bone Marrow Transplantation: Pattern of Recovery and Correlation With Cytomegalovirus Infection and Disease","volume":"78","author":"Reusser P.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI182317"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.07.026"},{"key":"e_1_2_12_29_1","volume-title":"The National Academies Collection: Reports Funded by National Institutes of Health","author":"Institute of Medicine (US) Committee to Study Priorities for Vaccine Development","year":"2000"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1086\/421999"},{"issue":"11","key":"e_1_2_12_31_1","first-page":"1176","article-title":"Multicenter Trial of Towne Strain Attenuated Virus Vaccine in Seronegative Renal Transplant Recipients","volume":"58","author":"Plotkin S. A.","year":"1994","journal-title":"Transplantation"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(84)90930\u20109"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003\u20104819\u2010114\u20107\u2010525"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199609053351007"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495\u2010199856010\u201000012"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700910"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12780"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2012.02.020"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001514"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.180115"},{"key":"e_1_2_12_41_1","doi-asserted-by":"crossref","unstructured":"R. W.Vernooij M.Michael J. M. T.Colombijn et\u00a0al. \u201cPre\u2010Emptive Treatment for Cytomegalovirus Viraemia to Prevent Cytomegalovirus Disease in Solid Organ Transplant Recipients \u201dCochrane Library accessed June 14 2026 https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD005133.pub4\/full.","DOI":"10.1002\/14651858.CD005133.pub4"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.6822"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056974"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14925"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2018.07.024"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2026.05.725"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2026.05.719"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(11)60136\u20100"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473\u20103099(25)00069\u20106"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473\u20103099(19)30107\u20100"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2025.06.025"},{"key":"e_1_2_12_52_1","unstructured":"K.Robinson \u201cPost\u2010Transplant Cyclophosphamide Mycophenolate Mofetil May Increase CMV Reactivation and Disease in Seropositive Patients \u201dASH Publications accessed December 03 2025 https:\/\/ashpublications.org\/ashclinicalnews\/news\/7012\/Post\u2010Transplant\u2010Cyclophosphamide\u2010Mycophenolate."},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.03.001"},{"key":"e_1_2_12_54_1","unstructured":"\u201cSeasonal RTI Vaccinations in Immunocompromised Patients \u201dIDSA accessed February 26 2026 https:\/\/www.idsociety.org\/Seasonal\u2010RTI\u2010Vaccinations\u2010in\u2010Immunocompromised\u2010Patients\/."},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.7326\/M19\u20102511"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102025\u20106007"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26824"},{"key":"e_1_2_12_58_1","unstructured":"\u201cDonation and Transplantation Statistics \u201dBlood Stem Cell accessed June 14 2026 https:\/\/bloodstemcell.hrsa.gov\/data\/donation\u2010and\u2010transplantation\u2010statistics."},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1814835116"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.1086\/314428"},{"key":"e_1_2_12_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473\u20103099(04)01202\u20102"},{"key":"e_1_2_12_62_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.7.4455"},{"key":"e_1_2_12_63_1","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2025.2497903"},{"key":"e_1_2_12_64_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01794\u201016"},{"key":"e_1_2_12_65_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000005260"},{"key":"e_1_2_12_66_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1800224115"},{"key":"e_1_2_12_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy102"},{"key":"e_1_2_12_68_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2025.6432"},{"key":"e_1_2_12_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad593"},{"key":"e_1_2_12_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa121"},{"key":"e_1_2_12_71_1","unstructured":"Hookipa Biotech GmbH \u201cA Randomized Placebo\u2010Controlled Phase 2 Study of HB\u2010101 a Bivalent Cytomegalovirus (CMV) Vaccine in CMV\u2010Seronegative Recipient (R\u2212) Patients Awaiting Kidney Transplantation From Living CMV\u2010Seropositive Donors (D+) \u201dClinicalTrials.Gov Clinical trial registration NCT03629080 accessed June 14 2026 https:\/\/clinicaltrials.gov\/study\/NCT03629080."},{"key":"e_1_2_12_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352\u20103026(15)00246\u2010X"},{"key":"e_1_2_12_73_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.284544"},{"key":"e_1_2_12_74_1","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00030\u201024"},{"key":"e_1_2_12_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3224"},{"key":"e_1_2_12_76_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.51974"},{"key":"e_1_2_12_77_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm3425"},{"key":"e_1_2_12_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41564\u2010022\u201001262\u20101"},{"key":"e_1_2_12_79_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz523"},{"key":"e_1_2_12_80_1","unstructured":"Hookipa Biotech GmbH \u201cA Randomized Placebo\u2010Controlled Phase 2 Study of HB\u2010101 a Bivalent Cytomegalovirus (CMV) Vaccine in CMV\u2010Seronegative Recipient (R\u2212) Patients Awaiting Kidney Transplantation From Living CMV\u2010Seropositive Donors (D+) \u201dClinicalTrials.Gov Clinical trial registration NCT03629080 accessed July 15 2026 https:\/\/clinicaltrials.gov\/study\/NCT03629080."},{"key":"e_1_2_12_81_1","unstructured":"\u201cCytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates \u201dClinicalTrials.Gov accessed July 15 2026 https:\/\/clinicaltrials.gov\/study\/NCT06075745."},{"key":"e_1_2_12_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100787"},{"key":"e_1_2_12_83_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.284256"},{"key":"e_1_2_12_84_1","unstructured":"City of Hope Medical Center \u201cPlacebo\u2010Controlled and Randomized Phase 2 Trial of CMV\u2010MVA Triplex Vaccination in HLA\u2010Matched Related Stem Cell Donors to Enhance CMV\u2010Specific Immunity and Prevent CMV Viremia in Recipients After Hematopoietic Stem Cell Transplant \u201dClinicalTrials.Gov Clinical Trial Registration NCT06059391 accessed July 21 2026 https:\/\/clinicaltrials.gov\/study\/NCT06059391."},{"key":"e_1_2_12_85_1","unstructured":"ModernaTX Inc. \u201cA Phase 2 Observer\u2010Blind Placebo\u2010Controlled Proof\u2010of\u2010Concept Trial to Evaluate Efficacy Safety and Immunogenicity of mRNA\u20101647 Cytomegalovirus Vaccine in Patients Who Have Undergone Allogeneic Hematopoietic Cell Transplantation (HCT) \u201dClinicalTrials.Gov Clinical Trial Registration NCT05683457 accessed July 15 2026 https:\/\/clinicaltrials.gov\/study\/NCT05683457."}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.70329","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/tid.70329","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.70329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:30:41Z","timestamp":1790440241000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tid.70329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,26]]},"references-count":84,"alternative-id":["10.1111\/tid.70329"],"URL":"https:\/\/doi.org\/10.1111\/tid.70329","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,26]]},"assertion":[{"value":"2026-07-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70329"}}